MOLECULES DE LIAISON POUR LE TRAITEMENT DU CANCER

• 收藏
• 分享

专利权人:

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

发明人:

KUENKELE, KLAUS-PETER,FENN, TIMOTHY,GARCIA-MARTINEZ, JUAN MANUEL,HO, JASON,KOESSL, CHRISTIAN,SEN, SAURABH,VOYNOV, VLADIMIR,WERNITZNIG, ANDREAS,SHAABAN, ABDULSALAM,ERYILMAZ, ERTAN,GANESAN, RAJKUMAR

申请号：

CA3046591

公开号：

CA3046591A1

申请日:

2017.12.21

申请国别(地区):

CA

年份:

2018

代理人:

摘要：

This invention relates to binding molecules that bind specifically to TNF-related apoptosis- inducing ligand receptor 2 (TRAILR2) and cadherin-17 (CDH17) and their use in medicine, pharmaceutical compositions comprising the same, and methods of using the same as agents for treatment and/or prevention of cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/